Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2011
09/09/2011CA2791476A1 Methods for purifying cells derived from pluripotent stem cells
09/09/2011CA2726403A1 Plants and seeds of spring canola variety scv119103
09/08/2011US20110219478 Recombinant antibodies to sclerotinia antigens
09/08/2011US20110219477 Cinerarium-derived chromosomal dna involved in synthesis of flavonoid, and use thereof
09/08/2011US20110219476 Glucuronyl transferase and polynucleotide encoding the same
09/08/2011US20110219475 Manipulation of Organic Acid Biosynthesis and Secretion
09/08/2011US20110219473 Pedicel specific promoter
09/08/2011US20110219464 Lung disease targets and uses thereof
09/08/2011US20110219462 G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases
09/08/2011US20110218332 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
09/08/2011US20110218234 Gene vector for inducing transgene-specific immune tolerance
09/08/2011US20110218232 Inhibitors of MRP4 and Agents Stimulating MRP4 Activity for the Treatment of Cardiac Disorders
09/08/2011US20110218229 SIRT1 Modulation of Adipogenesis and Adipose Function
09/08/2011US20110218219 Substituted sulphonamido phenoxybenzamides
09/08/2011US20110218211 Azaindole inhibitors of iap
09/08/2011US20110218210 Compounds for treating abnormal cellular proliferation
09/08/2011US20110218184 Quinolone analogs and methods related thereto
09/08/2011US20110218156 Molecular entities for binding, stabilization and cellular delivery of negatively charged molecules
09/08/2011US20110218154 Histone deacetylases, and uses related thereto
09/08/2011US20110218152 Compounds for stimulating p-glycoprotein function and uses thereof
09/08/2011US20110218150 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
09/08/2011US20110218145 Antibodies to modified human igf-1/e peptides
09/08/2011US20110218143 Compositions and methods for tissue repair
09/08/2011US20110218122 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides
09/08/2011US20110217779 Compositions and Methods for Non-Targeted Activation of Endogenous Genes
09/08/2011US20110217778 Leader Sequence to Boost Gene Expression
09/08/2011US20110217777 Process for the Extraction of Lipids from Microalgae Using Ionic Liquids
09/08/2011US20110217776 Transcription factor gene osnacx from rice and use thereof for improving plant tolerance to drought and salt
09/08/2011US20110217775 Methods for modulating osteochondral development using bioelectrical stimulation
09/08/2011US20110217774 Efficient and Universal Method for Neural Differentiation of Pluripotent Stem Cells
09/08/2011US20110217773 Method to restore cartilaginous phenotype of chondrocytes after cultured and expanded in vitro
09/08/2011US20110217772 Animal protein free media for cultivation of cells
09/08/2011US20110217771 Fluidic Culture Device
09/08/2011US20110217770 Cell Piercing Device and Method of Using Same
09/08/2011US20110217769 CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY
09/08/2011US20110217768 Novel lipase
09/08/2011US20110217767 Single-use Stationary Bioreactors and Mixing Vessels
09/08/2011US20110217749 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
09/08/2011US20110217734 Compositions and methods for the synthesis of appa-containing peptides
09/08/2011US20110217726 Method and kit for detecting biological signal of three-dimensional cell culture material
09/08/2011US20110217725 Cell culture kit, screening method, and method of manufacturing cell culture kit
09/08/2011US20110217724 Method of protecting cells
09/08/2011US20110217723 Epi-illumination apparatus and methods for sorting particles
09/08/2011US20110217722 Photo-damage apparatus and methods for sorting particles
09/08/2011US20110217695 BETAG1-IgG INTRON FOR ENHANCED ANTI-IGF1R EXPRESSON
09/08/2011US20110217414 Polypeptides having tyrosinase activity and polynucleotides encoding same
09/08/2011US20110217367 Means for inhibiting the expression of orc-1
09/08/2011US20110217332 Chimpanzee Adenovirus Vaccine Carriers
09/08/2011US20110217326 Method for diagnosing and/or treating tumor
09/08/2011US20110217324 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
09/08/2011US20110217321 Antibody drug conjugates (adc) that bind to 161p2f10b proteins
09/08/2011US20110217319 Methods of use of sialoadhesin factor-2 antibodies
09/08/2011US20110217318 Anti-platelet membrane glycoprotein vi monoclonal antibody
09/08/2011US20110217314 Methods and Compositions for Modulating Apoptosis
09/08/2011US20110217305 Anti-her2 antibodies and compositions
09/08/2011US20110217301 Methods for treating or screening for compounds for the treatment of sepsis
09/08/2011US20110217292 Monoclonal antibodies against hmgb1
09/08/2011US20110217291 Soluble hybrid fct receptors and related methods
09/08/2011US20110217279 Use of human biliverdin reductase and fragments thereof for the treatment of protein kinase c-delta and erk related conditions
09/08/2011US20110217274 Methods for production and uses of multipotent ,pluripotent, differentiated and disease-resistant cell populations
09/08/2011US20110217272 Treatment of radiation injury using placental stem cells
09/08/2011US20110217271 Treatment of diseases or disorders using placental stem cells
09/08/2011US20110217270 Methods for treating tumors and cancerous tissues
09/08/2011US20110217269 Method of fostering the healing of skin wounds using cells of the root sheath, composition and preparation method
09/08/2011US20110217267 Gene therapy vectors and cytosine deaminases
09/08/2011US20110217266 Genomic sequence of avian paramyxovirus type 2 and uses thereof
09/08/2011US20110217241 Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging
09/08/2011US20110217239 System and method of evaluating a protein of interest on tumor growth inhibition while following the tumor in vivo or in vitro
09/08/2011US20110217237 Therapeutic dll4 binding proteins
09/08/2011US20110215111 Method and apparatus for orienting sperm in a fluid stream
09/07/2011EP2363710A1 Isolation and identification of T cells
09/07/2011EP2363488A1 Postweaning multisystemic wasting syndrome virus from pigs
09/07/2011EP2363487A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
09/07/2011EP2363484A2 Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
09/07/2011EP2363473A1 Nitrile hydratase variant
09/07/2011EP2363472A1 Method for enhancing expression of recombinant protein
09/07/2011EP2363470A1 Method for introducing mutated gene, gene having mutation introduced therein, cassette for introducing mutation, vector for introducing mutation, and knock-in non-human mammal
09/07/2011EP2363468A1 Tumor antigen peptide and use thereof
09/07/2011EP2363466A1 Tannase, gene encoding same, and process for producing same
09/07/2011EP2363461A1 Fusion collagenase to which affinity tag is attached, and method for producing same
09/07/2011EP2363460A2 Acid fungal proteases
09/07/2011EP2363458A2 Terpene synthases
09/07/2011EP2363418A2 Method of obtaining recombinant mammalian myeloma cell lines adapted to growth in serum- and protein-free media
09/07/2011EP2363416A2 Anti-platelet membrane glycoprotein VI monoclonal antibody
09/07/2011EP2363406A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
09/07/2011EP2363404A2 PSMA antibodies
09/07/2011EP2363403A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
09/07/2011EP2363139A1 Method to increase class I presentation of exogenous antigens by human dendritic cells
09/07/2011EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases
09/07/2011EP2363137A2 Composition for preventing or treating aids containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as active ingredient
09/07/2011EP2363022A2 Use of oxygen antagonists for the therapeutic treatment of mammals
09/07/2011EP2362905A1 Screening method of anti-lung or esophageal cancer compounds
09/07/2011EP2362900A2 MAINTENANCE/EXPANSION OF HSCs
09/07/2011EP2362899A1 Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
09/07/2011EP2229434B1 Differentiation of human embryonic stem cells
09/07/2011EP2019861B1 Kidney-derived stem cell population, identification and therapeutic use
09/07/2011EP1996625B1 Anti-tat226 antibodies and immunoconjugates
09/07/2011EP1896596B1 Methods for altering the reactivity of plant cell walls
09/07/2011EP1877443B1 Monoclonal anti minichomosome maintenance 2 protein antibodies and methods for their use in the detection of cervical disease
09/07/2011EP1737950B1 Cells exhibiting neuronal progenitor cell characteristics